Diagnostics and laboratories deserves an expert voice.

Co-Diagnostics’ joint venture CoSara Diagnostics published a peer-reviewed study using the SARAGENE® HPV-HR test to screen 625 women in Central Gujarat. Twenty women tested positive for high-risk HPV; subsequent colposcopy/biopsy identified nine high-grade lesions and three invasive cervical cancers, including cases with negative cytology results.

Consider the potential role of validated molecular HPV PCR assays in expanding cervical screening strategies and lab service offerings, especially where cytology has limited sensitivity.

Consider: What laboratory validation steps and quality-control workflows are required to introduce a multiplex HPV PCR assay like SARAGENE® into routine screening programs in similar settings?

Quest Diagnostics reported an unauthorized party accessed patient records via its Quanum Lab Services Manager portal. The company paused Quanum LSM, investigated with outside cybersecurity experts, notified federal law enforcement, and later restored the system after remediation. Quest said some patient health, diagnostic and billing records were affected but has not disclosed the number of individuals involved.

Consider reviewing vendor-connected clinician portals, third-party integrations, and incident-response plans for lab and diagnostics operations that use or interface with external lab portals.

Consider: What specific access controls, logging, and multi-factor authentication measures do you have in place for third-party clinician portal integrations to reduce unauthorized access risk?

Yahoo Finance reports on this development. Read the source and add your perspective on what it means for your industry.

Consider: What does this development mean for businesses or customers in diagnostics and laboratories?

Bleeping Computer reports on this development. Read the source and add your perspective on what it means for your industry.

Consider: What does this development mean for businesses or customers in diagnostics and laboratories?

Fox Business on MSN reports on this development. Read the source and add your perspective on what it means for your industry.

Consider: What does this development mean for businesses or customers in diagnostics and laboratories?

Share practical expertise grounded in the linked industry sources and your own experience.

Consider: What should customers understand before making an important decision?

Share practical expertise grounded in the linked industry sources and your own experience.

Consider: Which priorities will matter most over the coming years, and why?